Literature DB >> 9346568

Acute liver failure: results of a 5-year clinical protocol.

M Daas1, D J Plevak, E F Wijdicks, J Rakela, R H Wiesner, D G Piepgras, W F Dunn, J L Steers.   

Abstract

This investigation summarizes and evaluates the results of a clinical protocol that we designed to care for patients with acute liver failure (ALF). Adult patients with ALF were enrolled in the protocol. Grade II portal-systemic encephalopathy prompted admission to the intensive care unit (ICU). Patients who met the clinical criterion were activated for liver transplantation. Intracranial pressure (ICP) was monitored in patients with grade III encephalopathy. An increase in ICP was treated with hyperventilation, diuretics, barbiturates, or a combination thereof. Survival was considered to have occurred if the patient left the hospital alive. Our series included 25 patients. Orthotopic liver transplantation (OLT) was performed on 19 patients, 12 of whom survived. Only 2 of 6 patients who did not undergo transplantation survived. Ten of 11 patients who underwent transplantation before reaching grade IV encephalopathy survived. Only 2 of 8 patients who underwent transplantation after reaching grade IV survived (P = .006). The causes of death included cerebral edema (3 patients), disseminated aspergillosis (3 patients), and other (5 patients). ICP was monitored in 11 patients. Increased pressure was documented by seven of the monitors placed. There was one focal hemorrhage secondary to a subdural monitor. Outcome is improved if transplantation occurs before grade IV encephalopathy. ICP monitoring can be accomplished without significant risk of hemorrhage. In our series, infection with aspergillus occurred frequently and with fatal outcome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9346568     DOI: 10.1002/lt.500010403

Source DB:  PubMed          Journal:  Liver Transpl Surg        ISSN: 1074-3022


  7 in total

1.  Brain preservation during orthotopic liver transplantation in a patient with acute liver failure and severe elevation of intracranial pressure.

Authors:  Alexandru Gottlieb; Kathrine R DeBoer
Journal:  J Gastrointest Surg       Date:  2005 Sep-Oct       Impact factor: 3.452

2.  Outcomes and complications of intracranial pressure monitoring in acute liver failure: a retrospective cohort study.

Authors:  Constantine J Karvellas; Oren K Fix; Holly Battenhouse; Valerie Durkalski; Corron Sanders; William M Lee
Journal:  Crit Care Med       Date:  2014-05       Impact factor: 7.598

3.  Intracranial Pressure Monitoring in Acute Liver Failure: Institutional Case Series.

Authors:  Patrick R Maloney; Grant W Mallory; John L D Atkinson; Eelco F Wijdicks; Alejandro A Rabinstein; Jamie J Van Gompel
Journal:  Neurocrit Care       Date:  2016-08       Impact factor: 3.210

4.  Intestinal glucose uptake protects liver from lipopolysaccharide and D-galactosamine, acetaminophen, and alpha-amanitin in mice.

Authors:  Laura Zanobbio; Marco Palazzo; Silvia Gariboldi; Giuseppina F Dusio; Diego Cardani; Valentina Mauro; Fabrizio Marcucci; Andrea Balsari; Cristiano Rumio
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

5.  Liver-assisting devices.

Authors:  Pramila Bajaj
Journal:  Indian J Anaesth       Date:  2009-12

6.  Structured approach to treat patients with acute liver failure: A hepatic emergency.

Authors:  Ramesh Kumar; Vikram Bhatia
Journal:  Indian J Crit Care Med       Date:  2012-01

7.  Prometheus therapy for the treatment of acute liver failure in patients after cardiac surgery.

Authors:  Ekaterina Komardina; Michael Yaroustovsky; Marina Abramyan; Marina Plyushch
Journal:  Kardiochir Torakochirurgia Pol       Date:  2017-12-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.